FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/04/065844 [Registered on: 16/04/2024] Trial Registered Prospectively
Last Modified On: 28/03/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Diagnostic 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Use And Effect Of Raktamitraka In Pandu Roga (ANAEMIA) 
Scientific Title of Study   A Comparative Pharmaceutico-Analytical Study And Clinical Efficacy Of Raktamitrarka W.S.R. To Pandu Roga (Anaemia) 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sandeep 
Designation  PG Scholar RSBK 
Affiliation  MMM.Goverment Ayurveda College Udaipur 
Address  Department of Rasshastra And Bhaishajya Kalpana MMM Goverment Ayurveda College Udaipur

Udaipur
RAJASTHAN
313001
India 
Phone  7073523228  
Fax    
Email  Sandeepmahla3228@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ajay Kumar Sharma 
Designation  Associate Professor 
Affiliation  MMM.Goverment Ayurveda College Udaipur 
Address  Department of Rasshastra And Bhaishajya Kalpana MMM Goverment Ayurveda College Udaipur

Udaipur
RAJASTHAN
313001
India 
Phone  9413257535  
Fax    
Email  sharmadrajay@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sandeep 
Designation  PG Scholar RSBK 
Affiliation  MMM.Goverment Ayurveda College Udaipur 
Address  Department of Rasshastra And Bhaishajya Kalpana MMM Goverment Ayurveda College Udaipur

Udaipur
RAJASTHAN
313001
India 
Phone  7073523228  
Fax    
Email  Sandeepmahla3228@gmail.com  
 
Source of Monetary or Material Support  
MMM.Goverment Ayurved College Udaipur Rajasthan 
 
Primary Sponsor  
Name  MMM Goverment Ayurveda College Udaipur 
Address  MMM. Goverment Ayurveda College Ambamata Udaipur Rajasthan 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sandeep  MMM Govt. Ayurveda College Udaipur   OPD No:2 PG Department of Rasashastra and Bhaishajya kalpana
Udaipur
RAJASTHAN 
7073523228

Sandeepmahla3228@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee MMM. Goverment Ayurved College Udaipur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:D649||Anemia, unspecified. Ayurveda Condition: PANDUROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Raktamitraarka, Reference: Sidha bhaishajya manimala,fourth gucha,Pandu roga,294, Route: Oral, Dosage Form: Arka, Dose: 25(ml), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 2 Months, anupAna/sahapAna: Yes(details: 50 ml luke warm water), Additional Information: All the ingredients will be collected and sealed in a earthern pot.Then pot will be covered with dung cakes and ignited by fire.This will be continued for 7 continous days.Ark will be obtained after heating the pot for 7 days over dung cakes.
2Intervention ArmDrugOther than Classical(1) Medicine Name: Raktamitraarka contemporary, Reference: NA, Route: Oral, Dosage Form: Arka, Dose: 25(ml), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 2 Months, anupAna/sahapAna: Yes(details: 50 ml luke warm water), Additional Information: All the ingredients will be sealed in an earthern pot.The pot will be kept in electric furnace and heated for 7 continous days and ark will be obtained.
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Sign and symptoms of Anaemia.
Evidence of Anaemia by lab investigations.
Participates in age group of 18-70 years.
Patients with Anaemia between 06gm %-10gm % of Haemoglobin 
 
ExclusionCriteria 
Details  Patients suffered with serious cardiac disorders like MI, Cardiac failure and Crisis
Patients having life threatening disease.
Patient having major illness like IDDM, DM which is poorly controlled or newly diagnosed or is taking new therapy or recently adjusted therapy.
Patient having Carcinoma.
Pregnant lady.
Patient with severe Anaemia below 06 gm% of Haemoglobin.
Patient suffering with Thalassemia, Bone marrow disorders, autoimmune disorders and Iron toxicity.
Patient himself or herself wants to withdraw from the clinical trial. 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Alternation 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Change in Quantity of Haemoglobin  60 days 
 
Secondary Outcome  
Outcome  TimePoints 
Anemia scale will be assessed  15 days,30 days & 45 days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   30/05/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is A Comparative Pharmaceutico -  Analytical Study And Clinical Efficacy of Raktamitrarka W.S.R. To Pandu Roga ( Anaemia). There will be 2 groups in the study, In Group A randomly selected and clinically diagnosed 30 patients of Pandu roga whose Hb gm % will be of 06 to 10 gm % .  Group A will be given Raktamitrarka prepared as per classical method and 30 patients of Group B randomly selected and clinically diagnosed will be given Raktamitrarka prepared by contemporary method.
Trial will be conduct for a period of 2 months. Follow up of the case will be after every 15 days that is 4 times during treatment. Final assessment will be done after completion of 2 months course on the basis of subjective, objective and laboratoral assessment.
The data will be analyzed  scientifically and statistically.
 
Close